Sanofi buys half of Merial from Merck for $4 billion

PARIS (Reuters) – French drugs group Sanofi-Aventis said on Thursday it was buying a 50 percent stake in animal health venture Merial from U.S. peer Merck for $4 billion to take full control of the business.

Leave a Reply